Bleichroeder LP’s Profound Medical PROF Stock Holding History

Bleichroeder LP’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Hold	254,753	–	–	0.3%	37
2026 Q1	$1.65M	Hold	254,753	–	–	0.29%	33
2025 Q4	$2M	Buy	254,753 +71,420	+39%	+$459K	0.35%	29
2025 Q3	$896K	Hold	183,333	–	–	0.17%	37
2025 Q2	$1.08M	Hold	183,333	–	–	0.27%	31
2025 Q1	$1.07M	Hold	183,333	–	–	0.28%	26
2024 Q4	$1.38M	Buy	183,333 +50,000	+38%	+$384K	0.35%	29
2024 Q3	$1.06M	Hold	133,333	–	–	0.29%	32
2024 Q2	$1.12M	Hold	133,333	–	–	0.33%	30
2024 Q1	$1.14M	Hold	133,333	–	–	0.28%	31
2023 Q4	$1.13M	Buy	+133,333	New	+$1.27M	0.25%	29

Other funds holding PROF

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ZCP

Z3 Capital Partners Richmond, Virginia $476M AUM

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Bleichroeder LP's PROF Position: Q2 2026 in Review

Bleichroeder LP held its Profound Medical (PROF) position steady in Q2 2026 at 254,753 shares worth $1.69M. The position accounts for 0.3% of the portfolio, ranked #37.

Bleichroeder LP first reported a position in PROF in Q4 2023 and has held it in 11 quarters since. The position peaked at $2M in Q4 2025. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

Bleichroeder LP held 254,753 shares of Profound Medical worth $1.69M as of Q2 2026.
Bleichroeder LP left its Profound Medical share count unchanged in Q2 2026.
Profound Medical made up 0.3% of Bleichroeder LP's portfolio in Q2 2026, its #37 holding.
Bleichroeder LP first reported a position in Profound Medical in Q4 2023 and has held it in 11 quarters since.
Bleichroeder LP's Profound Medical position peaked at $2M in Q4 2025.
56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.